Anticonvulsants (AEDs)

Anticonvulsants, also known as antiepileptic drugs (AEDs) or antiseizure medications (ASMs), are a diverse group of pharmacological agents primarily used to treat epileptic seizures by reducing excessive neuronal firing (StatPearls, 2023). This term does not refer to a single molecular target but rather a functional class of drugs that interact with various ion channels, neurotransmitter receptors, and transporters in the central nervous system (CNS) (PubMed, 2021). Key mechanisms include the inhibition of voltage-gated sodium and calcium channels, the enhancement of GABA-mediated inhibitory neurotransmission, and the antagonism of excitatory glutamate receptors (NIH, 2022). In addition to epilepsy, anticonvulsants are widely prescribed for neuropathic pain, bipolar disorder, and migraine prophylaxis (Mayo Clinic, 2023). Clinical use requires careful monitoring due to potential side effects such as CNS depression, metabolic disturbances, and severe hypersensitivity reactions like Stevens-Johnson syndrome (Wikipedia, 2024). The selection of a specific anticonvulsant depends on the seizure type, patient age, and potential drug-drug interactions (Epilepsy Foundation, 2023). Many of these agents work by stabilizing the inactive state of sodium channels, thereby preventing high-frequency repetitive firing of action potentials (PubChem, 2024). Others modulate the release of neurotransmitters by binding to the synaptic vesicle protein 2A (SV2A) or inhibiting the enzyme GABA transaminase (UniProt, 2023).

Other names

Antiepileptic drugsAntiseizure medicationsASMsAntiseizure drugsAEDs

Anticonvulsants exert their effects through several distinct mechanisms: blockade of voltage-gated sodium channels (e.g., carbamazepine), enhancement of GABAergic inhibition (e.g., phenobarbital), blockade of T-type calcium channels (e.g., ethosuximide), and modulation of synaptic vesicle protein SV2A (e.g., levetiracetam) (StatPearls, 2023; NIH, 2022).